Cadrenal Therapeutics, Inc. Common Stock
Cadrenal Therapeutics, Inc. Common Stock (CVKD) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CVKD · as of Jun 8, 2026
Key Statistics
Explore Cadrenal Therapeutics, Inc. Common Stock Data
cvkd stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
The CVKD analyst consensus is Buy, based on ratings from 1 Wall Street analysts over the past 3 months. The average 12-month price target is $32.00, representing +660.10% upside from the current price of $4.21.
Competitors & Peers
cvkd competitorsCVKD
CLGN
IBIO
ITRM
KLTO
NRSNStock Performance
Full HistoryAbout Cadrenal Therapeutics, Inc. Common Stock
Cadrenal Therapeutics, Inc. Common Stock Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise primarily engaged in clinical development. The company's core focus is the advancement of Tecarfarin, a novel therapeutic agent t…
what is cadrenal therapeutics, inc. common stock · cvkd stock overview · cadrenal therapeutics, inc. common stock company profile · who is cadrenal therapeutics, inc. common stock ceo · cvkd NASDAQ · cadrenal therapeutics, inc. common stock headquarters · cadrenal therapeutics, inc. common stock business segments
About Stock Overview & Key Data
Cadrenal Therapeutics, Inc. Common Stock (CVKD) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jan 20, 2023. As of the latest trading session, CVKD stock price is $4.21, with a market capitalization of $12.1M. The stock has returned -71.93% over the past 12 months and -37.91% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Cadrenal Therapeutics, Inc. Common Stock stock is Buy, with an average 12-month price target of $32.00. In fiscal year 2025, Cadrenal Therapeutics, Inc. Common Stock reported revenue of — and net income of -$13.2M. For detailed data — including Cadrenal Therapeutics, Inc. Common Stock revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Cadrenal Therapeutics, Inc. Common Stock (CVKD) stock price is $4.21. The stock is traded on NASDAQ under the ticker symbol CVKD. The 52-week range is $4.14 – $15.99.